Inspire Medical Systems, Inc.
INSPHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the. The company carries a $1.80B market cap, placing it firmly in the small-cap category. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.
Market Cap
$1.80B
Beta
0.70
P/E (TTM)
13.72
P/E (Fwd)
40.43
EPS (TTM)
$4.53
EPS (Fwd)
$1.54
ROE
18.0%
ROA
3.9%
Cash
$320.7M
Total Debt
$29.1M
Free CF
$94.6M
52W Change
-22.6%
Annual Financials
Cash vs Debt
Where INSP stands vs its 150-day and 200-day moving averages
As of the August 31, 2026 close, INSP finished 13.57% above its 150-day moving average ($54.10) and 8.05% below its 200-day moving average ($66.82). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is INSP overbought or oversold?
At the August 31, 2026 close, INSP's RSI(14) was 57.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $320.7M in cash and $29.1M in debt, INSP maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $94.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 18.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $407.9M (2022) to $912.0M (2025), reflecting a 124% increase over the period.
With cash comfortably exceeding debt, INSP has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Inspire Medical Systems, Inc.'s trajectory.